The development of the neurodegeneration molecular cascade is significantly influenced by nuclear factor erythroid 2-related factor 2 (Nrf2)-impaired signaling, which is fundamental to preventing oxidative stress and mitochondrial dysfunction and which is found to be compromised in patients with MS [33,34]. The gene discussed is NFE2L2; the disease is myeloid sarcoma.